ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Hellman Succeeds Perez As ASTR President Hanks Named President Elect; Kligerman Gold Medalist

November 5, 1982

Nurse Participation In International Congress Increases

September 19, 1986

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996

In Brief: Laird Myers Heads AACE, George Hill President Elect; Cal Tech’s Hood Receives Bertner Award

March 1, 1985

In Brief: David Tweardy named head of internal medicine at MD Anderson

September 19, 2014

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001